Search results
Results from the WOW.Com Content Network
Flu vaccines used during the flu in 2009. This is a list of vaccine-related topics.. A vaccine is a biological preparation that improves immunity to a particular disease.A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins.
This is a list of infectious diseases arranged by name, along with the infectious agents that cause them, the vaccines that can prevent or cure them when they exist and their current status. Some on the list are vaccine-preventable diseases .
A high-dose vaccine (Fluzone High-Dose) four times the strength of standard flu vaccine was approved by the FDA in 2009. [22] [23] [24] This vaccine is intended for people 65 and over, who typically have weakened immune response due to normal aging. The vaccine produces a greater immune response than standard vaccine.
A vaccine that is generally recommended may be medically inappropriate for a small number of people due to severe allergies or a damaged immune system. In addition, a vaccine against a given disease may not be recommended for general use in a given country, or may be recommended only to certain populations, such as young children or older adults.
Pneumococcal vaccine. Adults over 65 should get the pneumococcal vaccine, which protects against pneumococcal disease caused by bacteria, Dr. Kavasery says. These diseases include pneumonia, ear ...
A vaccine that contains the A/Vietnam/1194/2004 (H5N1) flu strain. [28] Pumarix: A vaccine approved for medical use in the European Union in March 2011. [29] Seqirus/Audenz: A vaccine for adults that contains a killed flu strain called A/Astrakhan/3212/2020 (H5N8)-like strain. [30] Some older H5N1 vaccines for humans that have been licensed are:
Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. [265] [19] [266] The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and ...
CoVLP is an example of a virus-like particle vaccine, consisting of a molecular complex which closely resembles a virus, but is non-infectious because it contains no viral genetic material. [8] It uses recombinant spike proteins derived from SARS-CoV-2 .